Last reviewed · How we verify
Preset increase in frusemide dose
At a glance
| Generic name | Preset increase in frusemide dose |
|---|---|
| Sponsor | Barts & The London NHS Trust |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Lung Impedance Monitoring In Treatment of Chronic Heart Failure (NA)
- The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Critically Ill Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Preset increase in frusemide dose CI brief — competitive landscape report
- Preset increase in frusemide dose updates RSS · CI watch RSS
- Barts & The London NHS Trust portfolio CI